Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end-stage kidney disease patients undergoing hemodialysis.
作者信息
Lee Szu-Ying, Chao Chia-Ter
机构信息
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan City, Taiwan.
出版信息
Clin Cardiol. 2024 May;47(5):e24281. doi: 10.1002/clc.24281.
Abstract
摘要
相似文献
1
Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end-stage kidney disease patients undergoing hemodialysis.探讨血管脆弱性在理解接受血液透析的终末期肾病患者血压变异性和死亡风险中的作用。
Clin Cardiol. 2024 May;47(5):e24281. doi: 10.1002/clc.24281.
2
Self-reported frailty among end-stage renal disease patients: A potential predictor of dialysis access outcomes.终末期肾病患者自我报告的衰弱：透析通路结局的潜在预测因素。
Nephrology (Carlton). 2017 Apr;22(4):333-334. doi: 10.1111/nep.12961.
3
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.维持性血液透析患者脉压与死亡率之间的关联。
JAMA. 2002 Mar 27;287(12):1548-55. doi: 10.1001/jama.287.12.1548.
4
Blood Pressure Variability and Frailty in End-Stage Kidney Disease.终末期肾病患者的血压变异性与虚弱
J Frailty Aging. 2024;13(4):534-540. doi: 10.14283/jfa.2024.61.
5
Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study.血压与晚期慢性肾脏病和血液透析患者全因死亡率的关系：慢性肾功能不全队列研究。
Hypertension. 2015 Jan;65(1):93-100. doi: 10.1161/HYPERTENSIONAHA.114.04334. Epub 2014 Oct 6.
6
Applicability of laboratory deficit-based frailty index in predominantly older patients with end-stage renal disease under chronic dialysis: A pilot test of its correlation with survival and self-reported instruments.基于实验室缺陷的衰弱指数在主要为慢性透析终末期肾病老年患者中的适用性：与生存和自我报告工具相关性的初步测试。
Nephrology (Carlton). 2020 Jan;25(1):73-81. doi: 10.1111/nep.13583. Epub 2019 May 6.
7
Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis.糖尿病肾病与慢性血液透析患者的虚弱有关。
Geriatr Gerontol Int. 2018 Dec;18(12):1597-1602. doi: 10.1111/ggi.13534. Epub 2018 Oct 11.
8
The Impact of Frailty on Technique Failure and Mortality in Patients on Home Dialysis.衰弱对居家透析患者技术失败和死亡率的影响。
Perit Dial Int. 2019 Nov-Dec;39(6):532-538. doi: 10.3747/pdi.2018.00195. Epub 2019 Oct 3.
9
Association between frailty and adverse outcomes in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.衰弱与维持性血液透析患者不良结局的关系：系统评价和荟萃分析。
Ren Fail. 2024 Dec;46(2):2367716. doi: 10.1080/0886022X.2024.2367716. Epub 2024 Aug 5.
10
Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.终末期肾病血液透析患者高血压的评估与治疗
Curr Cardiol Rep. 2016 Dec;18(12):125. doi: 10.1007/s11886-016-0805-y.
本文引用的文献
1
Interdialytic home systolic blood pressure variability increases all-cause mortality in hemodialysis patients.间歇性血液透析患者透析间期家庭收缩压变异性增加全因死亡率。
Clin Cardiol. 2024 Apr;47(4):e24259. doi: 10.1002/clc.24259.
2
Vascular calcification in CKD: New insights into its mechanisms.慢性肾脏病中的血管钙化：对其发病机制的新认识。
J Cell Physiol. 2023 Jun;238(6):1160-1182. doi: 10.1002/jcp.31021. Epub 2023 Jun 3.
3
Vascular frailty, a proposal for new frailty type: A narrative review.血管脆弱性：一种新的脆弱类型的提议——一篇叙述性综述
Kaohsiung J Med Sci. 2023 Apr;39(4):318-325. doi: 10.1002/kjm2.12664. Epub 2023 Mar 3.
4
Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.尿毒症毒素与慢性肾脏病患者的虚弱：分子视角
Int J Mol Sci. 2021 Jun 10;22(12):6270. doi: 10.3390/ijms22126270.
5
Applicability of laboratory deficit-based frailty index in predominantly older patients with end-stage renal disease under chronic dialysis: A pilot test of its correlation with survival and self-reported instruments.基于实验室缺陷的衰弱指数在主要为慢性透析终末期肾病老年患者中的适用性：与生存和自我报告工具相关性的初步测试。
Nephrology (Carlton). 2020 Jan;25(1):73-81. doi: 10.1111/nep.13583. Epub 2019 May 6.
Zotero 插件